Legal representatives from Bindmans, acting for the Stop Oxevision campaign, urged the Information Commissioner’s Office to inspect whether Oxevision's patient data collection complies with the law.

Overview Debates Related claims Topics Sources

NHS England identified 57 national incidents where hospital staff used Oxevision's 15-second video preview function on devices instead of conducting mandatory in-person patient observations.

Five patients killed themselves or died unexpectedly over two years while surveilled by Oxevision infrared cameras at Essex Partnership University NHS Foundation Trust.

Barrister Brenda Campbell KC told the Lampard Inquiry that Oxevision bedroom cameras cause significant privacy invasions and create a coercive power imbalance on psychiatric wards.

In 2026, the Information Commissioner launched a separate watchdog inquiry into Oxevision manufacturer Lio Health regarding data protection concerns in mental health wards.

Essex Partnership University NHS Foundation Trust introduced an opt-in policy for Oxevision in August 2026 after acknowledging that assuming implied consent upon patient admission was wrong.

Essex Partnership University NHS Foundation Trust required mental health inpatients requesting to turn off bedroom cameras to wait up to 72 hours for a multidisciplinary clinical team decision.

Doctor's offices across the United States regularly require patients to sign consent forms permitting health data access for medical training and artificial intelligence development as a condition of receiving care.

Canada should exclude mental illness as a sole condition for medically assisted dying

Outro plans to use its $7 million in capital to expand its network of deprescribing clinicians and develop artificial intelligence clinical decision support tools.

Approximately one in six Americans take an antidepressant medication, and average duration of use has surpassed five years.

Outro's deprescribing platform incorporates personalized hyperbolic tapering plans, compounded medication doses, patient monitoring, and specially-trained clinicians.

Outro plans to expand its tapering model into additional medication classes beyond antidepressants, including benzodiazepines, gabapentinoids, and GLP-1s.

Research led by Dr. Mark Horowitz found that four in five long-term antidepressant users were unable to stop taking their medications due to withdrawal symptoms.

Hyperbolic tapering is the most effective protocol for discontinuing psychiatric medications

Commercial digital platforms are suitable for managing complex psychiatric drug withdrawal

U.S. healthcare providers should prioritize deprescribing over long-term psychiatric medication maintenance

FDA approval standards based on short-term trials adequately protect long-term antidepressant users

Victoria should launch targeted public health campaigns on cannabis risks for young women

Cannabis-related admissions create an unsustainable strain on Victoria's public health system

Cannabis consumption poses a severe public health risk through induced psychosis